
	Where results make sense

Topic: Biosciences

Related Topics

Alevites

Bushnell

Stelleroidea

Giorgi Mazniashvili

Secretary of State

Herbert Block

InuYasha voice actors

In the News (Mon 28 May 12)

EXECUTIVE POWER

Iran

ANALYSIS

Pakistan

Family compact

	Mathematical Biosciences. (Site not responding. Last check: 2007-10-26)
		Michiel van Boven, Hester E. de Melker, Joop F.P. Schellekens, Mirjam Kretzschmar, Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands, Mathematical Biosciences 164 (2) (2000) pp.
		Rinaldo B. Schinazi, Horizontal versus vertical transmission of parasites in a stochastic spatial model, Mathematical Biosciences 168 (1) (2000) pp.
		Rinaldo B. Schinazi, On the importance of risky behavior in the transmission of sexually transmitted diseases, Mathematical Biosciences 173 (1) (2001) pp.
	www.elsevier.com /cdweb/journals/00255564/viewer.htt?viewtype=authors&rangeselected=37 (488 words)

	Amersham plc: Amersham Biosciences
		Amersham Biosciences provides scientists with the tools to investigate the genetic and molecular basis for human development and disease, and to apply this knowledge to the discovery of new drugs and the manufacture of biologically-based medicines.
		Amersham Biosciences is a leading global provider of products and services used in gene, protein and cell research, drug discovery and development, and biopharmaceutical manufacturing.
		Amersham Biosciences' customers include universities, medical schools and academic centres of excellence around the world, private and publicly funded research organisations, and pharmaceutical and biotechnology companies.
	www.amersham.com /businesses/Biosciences.html (428 words)

	EMD Biosciences: Employee Benefits Overview
		You must be a Full-Time employee of EMD Biosciences to be eligible to participate in the various benefit plans.
		EMD Biosciences contributes 30% of the first 6% of pay that the employee contributes to the plan.
		EMD Biosciences offers an amount annually to be used towards the cost of your membership for the gym of your choice.
	www.emdbiosciences.com /html/emd/careers_benefits.htm (687 words)

	Biosciences
		The Journal of Biosciences is a quarterly journal published by the Indian Academy of Sciences, Bangalore.
		The Journal of Biosciences began in 1934 as the Proceedings of the Indian Academy of Sciences (Section B).
		Proceedings-Experimental Biology was renamed Journal of Biosciences in 1979; and in 1991, Proceedings-Animal Sciences and Proceedings-Plant Sciences merged with it.
	www.ias.ac.in /jbiosci (145 words)

	Akin Gump Strauss Hauer Feld & LLP- practice
		With clients ranging in size from inventors just starting the process of commercializing their inventions to large multinational pharmaceutical companies, we are thoroughly familiar with the issues and risks facing all types of biosciences companies and investors and the strategies necessary to handle those issues and risks.
		In the biosciences area, perhaps more than any other, meeting the letter of the law with respect to regulatory requirements is no longer sufficient to commercialize and maintain markets for new products.
		Instead, a successful commercialization often requires detailed and experienced assessment of the political forces at play in the relevant markets and a stepwise strategy to educate and positively engage decision makers and their constituents prior to and during the regulatory approval process.
	www.akingump.com /practice.cfm?practice_id=74 (1255 words)

	ACE BioSciences A/S
		ACE BioSciences is an emerging pharmaceutical company focused on developing novel, protein-based vaccines and antibodies to address infectious diseases caused by pathogens such as bacteria, fungi and viruses.
		ACE BioSciences' competitive advantage is founded on its unique expertise in the extraction and analysis of the cell surface proteins used by pathogens to interact with and infect human host cells.
		ACE BioSciences has the skills to isolate novel proteins as potential new drug targets (as opposed to working on known pathogen proteins).
	www.acebiosciences.com (251 words)

	LION bioscience Announces Partnership with ACE BioSciences
		ACE BioSciences will apply these modules to conduct its own proteomics research in the field of pathogenic microorganisms and deliver proprietary content for LION's piSCOUT(TM) software for the analysis of protein-protein interactions on an exclusive basis.
		About ACE BioSciences A/S: ACE BioSciences A/S (http://www.acebiosciences.com) is a biology driven biotech company with expertise in functional proteomics.
		ACE BioSciences has to date established alliances with Micromass, UK, IBM Lifesciences division, the Statens Serum Institute, Copenhagen and the University of Southern Denmark, Odense.
	www.prnewswire.com /cgi-bin/stories.pl?ACCT=104&STORY=/www/story/11-06-2001/0001609122&EDATE= (799 words)

	Arcadia Biosciences
		Arcadia Biosciences is developing agricultural products to capitalize on opportunities that benefit the environment and enhance human health.
		Arcadia Biosciences is committed to sharing its technologies with growers in the developing world.
		September 20, 2005 - Arcadia Biosciences and Monsanto Company (NYSE: MON) today announced a licensing agreement for the development and commercialization of Arcadia’s nitrogen use efficiency (NUE) technology in canola.
	www.arcadiabio.com (147 words)

	School of Biosciences (Site not responding. Last check: 2007-10-26)
		The School of Biosciences is allocated studentships by BBSRC, MRC, NERC and other bodies.
		Research students at the School are members of the Biosciences Graduate Research School, and receive training in many generic and transferable skills in addition to those that are specific to their research discipline.
		This page is maintained by the School of Biosciences.
	www.biosciences.bham.ac.uk /prospective/postgraduate/phd.htm (944 words)

	Helios Biosciences - Target Designer
		Dynamic models: Helios Biosciences offers a new paradigm in systems biology: by introducing the dynamic dimension in the study of biological regulatory pathways, accurate therapeutic targets can be characterized using fast and cost-efficient techniques.
		Tissue and cell expression: Helios BioSciences' know-how and 20 years of expertise have enabled our company to optimize mRNA and protein expression analyses, using fast and cost-efficient techniques.
		Helios Biosciences presents the scientific strategy of its drug targeting program for temporal lobe epilepsy during the 26th International Epilepsy Congress in Paris (France).
	www.helios-bioscience.com (493 words)

	YM Bioscience Inc.
		YM BioSciences completed enrolment of its 700 patient pivotal trial of tesmilifene for the treatment of rapidly progressing metastatic and recurrent breast cancer in September 2005.
		In addition to tesmilifene, YM BioSciences is developing nimotuzumab, an anti-EGFr humanized monoclonal antibody, in a number of indications including glioma, head and neck, NSCLC, and pancreatic cancers.
		YM BioSciences is also developing its anti-GnRH, anti-cancer vaccine, Norelinâ¢, for which Phase II data have been released.
	www.ymbiosciences.com (457 words)

	Biotechnology Information Directory - Products (Site not responding. Last check: 2007-10-26)
		Bridge Bioscience Laboratory instrumentation for electroporation, electrophoresis, concentrators, heatring and chilling, and reagents.
		JRH Biosciences Providing cell culture reagents and services to develop and produce biopharmaceuticals using mammalian and insect cell culture methods.
		Martek Biosciences Reagents and technologies to visualize molecular interactions for drug discovery and development, including fluorescent markers for diagnostics, rapid miniaturized screening, and gene and protein detection.
	www.cato.com /biotech/bio-prod.html (6611 words)

	Biosciences \| The WWW Virtual Library
		Subject pages on: gametogenesis and fertilization, early development, organogenesis and morphogenesis, pattern formation, gene regulation and genetics, cell lineage and fate maps, evolution and development, diseases, defects and development.
		The Virtual Library of Genetics is sponsored by the U.S. Department of Energy Office of Science, Office of Biological and Environmental Research.
		Whale watching as a commercial activity began in 1955 in North America along the southern California coast.
	vlib.org /Biosciences.html (500 words)

	Troy Biosciences, Inc.
		Troy Biosciences is a world leader in the development of controlled release pheromone products for use in agriculture.
		Troy Biosciences was one of the first companies to be awarded a patent for the development of a controlled release mechanism which allows these pheromones to be used in a cost-effective manner.
		Troy Biosciences is at the forefront of developing products and programs which allow growers to significantly reduce their dependency on pesticides.
	www.troybiosciences.com (455 words)

	JRH Biosciences, Inc. (Site not responding. Last check: 2007-10-26)
		JRH Biosciences develops, manufactures and markets cell culture reagents and services targeted for commercial firms involved in developing and producing biopharmaceuticals using mammalian and insect cell culture methods.
		These warranties and JRH Biosciences' performance of its obligations shall be governed by the laws of the State of Kansas.
		JRH Biosciences hereby rejects any terms or conditions submitted by a purchaser which are in conflict with or enlarge the terms of this Limited Warranty, whether or not JRH Biosciences actually notifies purchaser of such rejection or objection.
	www.jrhbio.com /JRH.aspx?About (1911 words)

	Biosciences \| The WWW Virtual Library
		this resource in English is indexed under: Biosciences.
		this resource in English is indexed under: Biosciences, History.
		this resource in English is indexed under: Agriculture, Biosciences.
	vlib.org /Biosciences (500 words)

	Kansas City University of Medicine and Biosciences
		When you submit personal information to Kansas City University of Medicine and Biosciences, you understand and agree that Kansas City University of Medicine and Biosciences and its subsidiaries, affiliates and trusted vendors may transfer, store, and process your profile.
		While Kansas City University of Medicine and Biosciences uses cookies to track your visit, our Web Site and our Web servers automatically log the IP/Internet address of your computer, this information does not identify you personally and you remain anonymous unless you have otherwise provided Kansas City University of Medicine and Biosciences with personal information.
		Please note that Kansas City University of Medicine and Biosciences is not responsible for the content or privacy practices of any other website that Kansas City University of Medicine and Biosciences may link to.
	www.kcumb.edu /help/security.asp (431 words)

	BD (Becton, Dickinson and Company) - Press Kit - BD Biosciences News
		Atto Bioscience, Inc. reported sales of $3 million for calendar year 2003 and is expected to double its sales for calendar year 2004.
		BD Biosciences Continues Support of IAVI in Quest for Preventive AIDS Vaccines: BD Biosciences is strengthening its ties with IAVI to help speed scientific progress toward finding safe, effective, and accessible preventive AIDS vaccines by committing to a research and development (RandD) collaboration.
		BD Bioscience Enters into Collaboration with the Harvard Institute of Proteomics to Determine Human Gene Function: BD Biosciences has entered into a collaboration with the Harvard Institute of Proteomics (HIP) at Harvard Medical School to generate thousands of DNA constructs containing genes involved in biological processes.
	www.bd.com /press/press_kits/bdbiosciences/news (2281 words)

	Comparative Biosciences Inc. - Preclinical activities and drug development services
		Comparative Biosciences Inc. is committed to providing expert resources and quality service to all sectors of the biomedical community.
		The mission at Comparative Biosciences Inc. is to provide the same level of excellence to the determined biotech startup that we deliver on a scaleable level to the largest pharmaceutical company.
		Follow the links at the top to learn more about Comparative Biosciences, Inc., our array of capabilities and services, and our commitment to ongoing excellence in biomedicine.
	www.compbio.com (133 words)

	Synthetic Biology at Berkeley Lab - Physical Biosciences Division (Site not responding. Last check: 2007-10-26)
		The Physical Biosciences Division at Lawrence Berkeley National Laboratory established the world’s first Synthetic Biology Department, which seeks to understand and design biological systems and their components to address a host of problems that cannot be solved using naturally-occurring systems.
		Berkeley Lab and UC Berkeley have joined forces to establish the Berkeley West Biocenter, a multidisciplinary research facility in synthetic biology, cell and molecular biology, cancer research, and quantitative biology.
		The 72,000 square-foot space, with its excellent laboratory facilities and prime location in the heart of the Bay Area bioscience hub, is perfectly suited to the technical demands of today’s biosciences.
	www.lbl.gov /LBL-Programs/pbd/synthbio (374 words)

	Egea Biosciences, Inc. (Site not responding. Last check: 2007-10-26)
		The acquisition of Egea, the pioneers of a technology platform designed to optimize protein therapeutics, will strengthen Centocor's position as a leader in biomedicines and protein therapeutics technology.
		Egea Biosciences was founded in 2000 by Glen Evans, M.D., Ph.D. Prior to establishing Egea, Dr. Evans was a leading investigator in the Human Genome Project and held positions at the University of Texas Southwestern Medical Center at Dallas, and at the Salk Institute.
		Egea's platform technology enables, for the first time, the optimization of biologics and antibodies for therapeutic use through proprietary large-scale gene synthesis.
	www.egeabiosciences.com (367 words)

	Predicant Biosciences - Employment (Site not responding. Last check: 2007-10-26)
		Predicant Biosciences is an emerging life sciences company founded in 2002 that is developing technology for identifying and assaying protein biomarker patterns.
		The integrated Predicant system being developed consists of proprietary separations, detection and informatics technologies utilizing minimally invasive procedures.
		We offer highly competitive compensation and benefits packages, including equity participation, commensurate with background and experience.
	www.biospect.com /employment.htm (103 words)

	Welcome to Progen Biosciences (Site not responding. Last check: 2007-10-26)
		You may be aware that Quantum Scientific was acquired by Global Science and Technology who are distributors of scientific equipment and consumables in the New Zealand market.
		Quantum Scientific wish to advise all of our loyal friends and customers that it is the intention of the Directors of Global Science and Technology to merge the Quantum Scientific and Progen Bioscience businesses in Australia effective from the 1st July 2005.
		The name and logo of Quantum Scientific will be unchanged and Progen Biosciences will be a product group managed by Rod Stewart within the merged company.
	www.probiogen.com (374 words)

	SRI International's Biosciences Division is a contract research organization (CRO) that provides complete preclinical ...
		SRI International's Biosciences Division is a contract research organization (CRO) that provides complete preclinical services
		SRI Biosciences provides complete drug and biologic discovery and development services to take drugs from "Idea to IND." Learn how SRI can help you move your lead compound from the lab bench to the clinic by clicking on the map below, on the subject list to the right, or the detailed
		SRI Biosciences is a preclinical contract research organization (CRO) whose services include basic research, target validation, lead discovery and optimization, radiochemical synthesis, in vitro and in vivo efficacy testing, formulation, in vitro toxicology screening, GLP safety pharmacology and toxicology, pharmacokinetics, metabolism, GMP manufacturing of clinical trial materials, quality assurance, and IND preparation and submission.
	www.sri.com /biosciences (185 words)

	Kosan Biosciences (Site not responding. Last check: 2007-10-26)
		Kosan Biosciences Incorporated (NASDAQ:KOSN) today announced that its Phase II clinical trial of KOS-862 (Epothilone D) as monotherapy for patients with metastatic breast cancer will proceed to full enrollment of the study following the successful completion of the interim analysis.
		The multi-center Phase II study is being conducted according to a two-stage Simon trial design, in which the primary objective must be met in the first stage of the trial before proceeding to the second stage.
		Kosan Biosciences has two first-in-class anticancer agents in Phase II and Phase Ib clinical trials: KOS-862 (Epothilone D) and 17-AAG, an Hsp90 inhibitor and geldanamycin analog.
	www.kosan.com /news_view_pr.cfm?id=242 (611 words)

Try your search on: Qwika (all wikis)